New Graphic Narrative Patient Discussion Guides
Three new clinical discussion guides tailored for patients with breast, lung, and prostate cancer have been added to the Communicating the External Beam Radiotherapy Experience (CEBRE) series. These unique discussion guides use graphic narrative as a tool to facilitate patient-physician communication during the initial consultation prior to radiotherapy. In 2019, Daniel Golden, MD, MHPE, received a Personalized Radiation Therapy Award from the ROI to build upon the success of the initial CEBRE guide that he developed with his team and to create three new guides customized by disease site that would help patients better understand what to expect during treatment.
The CEBRE guides are the result of a unique collaboration between radiation oncologists at the University of Chicago and design experts at the Illinois Institute of Technology Institute of Design. The multidisciplinary team led by Dr. Golden includes Ritu Arya, MD, and Professor of Design Tomoko Ichikawa, MS. They set out to tackle two challenges: most patients often know little about the external beam radiotherapy process and many of the existing patient education materials about radiotherapy are written at an average of a tenth-grade reading level. The CEBRE guides are written at a sixth-grade reading level and use graphic narrative to explain the external beam radiotherapy process. The three new guides address the unique challenges that patients could experience related to the site-specific treatment processes and treatment related toxicities and seek to alleviate the distinct concerns and anxiety particular to radiotherapy for breast, lung, and prostate cancer.
The CEBRE guides are free to download and can be customized by clinic. They are designed to be printed on 11 x 17 copy paper on a standard color office printer. A preview of each of the new personalized guides is included through the links below, and they will be available to download for clinical use through the CEBRE website soon.
The ROI is excited to share this wonderful new resource with the radiation oncology community and is pleased to be supporting Dr. Golden’s team as they develop three additional disease site-specific CEBRE guides for head and neck, central nervous system, and gastrointestinal malignancies to be released next year.